CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to enhance cancer treatment by developing mathematical and computational tools to identify personalized drug combinations. By analyzing patient-derived samples, it seeks to prevent drug resistance and improve therapeutic strategies for leukemia and ovarian cancer patients.
Making cancer treatment more personalized and effective is one of the grand challenges in our health care system.
However, many drugs have entered clinical trials but so far showed limited efficacy or induced rapid development of resistance.
We critically need multi-targeted drug combinations, which shall selectively inhibit the cancer cells and block the emergence of drug resistance.
This project will develop mathematical and computational tools to identify drug combinations that can be used to…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
